Documents

Demetrio Neri Stem cell science and policies: the Italian debate and legislation in a European perspective. Introductory remarks. My presentation consists of two sections. In the first section I’ll try to answer to the question which is the issue of this session. Perhaps my answer will sound a bit pessimistic, but what happened at the

Lecturer/Position/Organization: Charles H. Baron/Professor/Boston College Law School Session/Theme: Science and Law Title of the presentation: Legal Methodologies for Maximizing Freedom of Scientific Research In the realm of American law, there may be no more quoted statement from a judicial opinion than that of U.S. Supreme Court Justice Louis Brandeis who observed in a 1932 case:

Tiziano Barberi (PhD, senior scientist in the laboratory of Stem Cell and Tumor Biology at Memorial Sloan-Kettering Cancer Center, New York) Session: Science, Technology and Economy Round table: Open Access to Science Impact of open access in biomedical research Open access to science comes from one of the initiatives of the Open Society Institute (OSI).

Stem Cells and Public Opinion Giulio Cossu (Director, Stem Cell Research Institute Dibit, H. San Raffaele) “The experience of the Italian referendum on stem cells�? It is now approximately one year since a heated and convulse campaign on the referendum started to reach a peak of animosity and verbal violence few days before the selected

Mino Vianello Facolta’ di Statistica, ” La Sapienza” Descartes Prize E’ naturale, visto il contesto in cui nasce – contesto non solo italiano, anche se in Italia particolarmente scottante dopo l’introduzione d’una legge sulla fecondazione assistita che tocca direttamente il tema della sperimentazione con le cellule staminali embrionali – e’ naturale, dicevo, che quasi implicitamente

Speaker/Position/Organization Daniel Perry, Past President (2004-2005) and Current Vice President,Coalition for the Advancement of Medical Research (CAMR), USA – Executive Director Alliance for Aging Research Washington, DC Session: Stem Cell Science and Policies (Part I) Friday, Feb. 17, 8:30 AM Title: “Regenerative Medicine Under Attack in America: How Scientists and Patients Are Responding�? Regenerative medicine

Lecturer/Position/Organization: Prof. Miodrag Stojkovic, Deputy Director, Centre for Stem Cell Biology and Developmental Genetics, University of Newcastle, UK; Deputy Director Principe Felipe Centre, Valencia, Spain Session/Theme: Stem Cells Science and Policies Title of the presentation: Progress in nuclear transfer technique and embryonic stem cell biology: too fast, too scary? Nuclear transfer (NT) technique requires the

Bernard Siegel, Executive Director, Genetics Policy Institute Building a Global Constituency for Stem Cell Research Scientific developments, as well as controversies, in stem cell research and nuclear transfer continue. As researchers demonstrate the potential of regenerative medicine, politicians and international organizations continue to scrutinize this work, and some seek to limit or ban it. This

Lecturer/Position/Organization: Debra JH Mathews, PhD, MA Assistant Director for Science Programs, Phoebe R Berman Bioethics Institute, Johns Hopkins University Session/Theme: Stem Cell Science and Polices/In the USA Title of the presentation: Interstate Collaboration in Stem Cell Research Text: (recommended/maximum length: 1 page) Embryonic stem cells (ESCs) are immensely promising for both basic science and clinical

Lecturer/Position/Organization: Carl Djerassi, Professor of Chemistry emeritus, Stanford University Session/Theme: Science/Society and Politics Title of the presentation: Can research be forbidden The answer to the question posed in my title is a categorical “No!�? It would be equivalent to prohibiting human curiosity, which is patently impossible, because in the final analysis, it is human curiosity